Lv3
340 积分 2025-08-10 加入
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
9小时前
已完结
Predictive role of nutritional and immune-inflammatory indexes in the diagnostic work-up and risk stratification of heart failure with preserved ejection fraction
3个月前
已完结
Immunomodulatory Therapy for Ischemic Heart Disease
7个月前
已完结
皖公网安备34019202002308
